Does ALECTINIB Cause Neoplasm malignant? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Neoplasm malignant have been filed in association with ALECTINIB (ALECENSA). This represents 0.8% of all adverse event reports for ALECTINIB.
69
Reports of Neoplasm malignant with ALECTINIB
0.8%
of all ALECTINIB reports
11
Deaths
10
Hospitalizations
How Dangerous Is Neoplasm malignant From ALECTINIB?
Of the 69 reports, 11 (15.9%) resulted in death, 10 (14.5%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALECTINIB. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does ALECTINIB Cause?
Death (702)
Fatigue (618)
Constipation (525)
Off label use (495)
No adverse event (488)
Disease progression (366)
Rash (312)
Dyspnoea (296)
Drug ineffective (269)
Myalgia (268)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ALECTINIB Alternatives Have Lower Neoplasm malignant Risk?
ALECTINIB vs ALEMTUZUMAB
ALECTINIB vs ALENDRONATE
ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL
ALECTINIB vs ALENDRONIC ACID
ALECTINIB vs ALEVE